109 related articles for article (PubMed ID: 17440072)
21. Immunohistochemical expression and significance of epidermal growth factor receptor (EGFR) in breast cancer.
Meche A; Cîmpean AM; Raica M
Rom J Morphol Embryol; 2009; 50(2):217-21. PubMed ID: 19434314
[TBL] [Abstract][Full Text] [Related]
22. Altered receptor trafficking in Huntingtin Interacting Protein 1-transformed cells.
Rao DS; Bradley SV; Kumar PD; Hyun TS; Saint-Dic D; Oravecz-Wilson K; Kleer CG; Ross TS
Cancer Cell; 2003 May; 3(5):471-82. PubMed ID: 12781365
[TBL] [Abstract][Full Text] [Related]
23. Intrasteric inhibition mediates the interaction of the I/LWEQ module proteins Talin1, Talin2, Hip1, and Hip12 with actin.
Senetar MA; Foster SJ; McCann RO
Biochemistry; 2004 Dec; 43(49):15418-28. PubMed ID: 15581353
[TBL] [Abstract][Full Text] [Related]
24. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
[TBL] [Abstract][Full Text] [Related]
25. Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking.
Madshus IH; Stang E
J Cell Sci; 2009 Oct; 122(Pt 19):3433-9. PubMed ID: 19759283
[TBL] [Abstract][Full Text] [Related]
26. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
Theodoropoulos GE; Karafoka E; Papailiou JG; Stamopoulos P; Zambirinis CP; Bramis K; Panoussopoulos SG; Leandros E; Bramis J
Anticancer Res; 2009 Feb; 29(2):785-91. PubMed ID: 19331236
[TBL] [Abstract][Full Text] [Related]
27. Control of cell motility by interaction of gangliosides, tetraspanins, and epidermal growth factor receptor in A431 versus KB epidermoid tumor cells.
Park SY; Yoon SJ; Freire-de-Lima L; Kim JH; Hakomori SI
Carbohydr Res; 2009 Aug; 344(12):1479-86. PubMed ID: 19559406
[TBL] [Abstract][Full Text] [Related]
28. RME-8 regulates trafficking of the epidermal growth factor receptor.
Girard M; McPherson PS
FEBS Lett; 2008 Mar; 582(6):961-6. PubMed ID: 18307993
[TBL] [Abstract][Full Text] [Related]
29. HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
Press MF; Finn RS; Cameron D; Di Leo A; Geyer CE; Villalobos IE; Santiago A; Guzman R; Gasparyan A; Ma Y; Danenberg K; Martin AM; Williams L; Oliva C; Stein S; Gagnon R; Arbushites M; Koehler MT
Clin Cancer Res; 2008 Dec; 14(23):7861-70. PubMed ID: 19047115
[TBL] [Abstract][Full Text] [Related]
30. Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
Bremm A; Walch A; Fuchs M; Mages J; Duyster J; Keller G; Hermannstädter C; Becker KF; Rauser S; Langer R; von Weyhern CH; Höfler H; Luber B
Cancer Res; 2008 Feb; 68(3):707-14. PubMed ID: 18245470
[TBL] [Abstract][Full Text] [Related]
31. Distinctive E-cadherin and epidermal growth factor receptor expression in metastatic and nonmetastatic head and neck squamous cell carcinoma: predictive and prognostic correlation.
Muller S; Su L; Tighiouart M; Saba N; Zhang H; Shin DM; Chen Z
Cancer; 2008 Jul; 113(1):97-107. PubMed ID: 18473353
[TBL] [Abstract][Full Text] [Related]
32. Disruption of the endocytic protein HIP1 results in neurological deficits and decreased AMPA receptor trafficking.
Metzler M; Li B; Gan L; Georgiou J; Gutekunst CA; Wang Y; Torre E; Devon RS; Oh R; Legendre-Guillemin V; Rich M; Alvarez C; Gertsenstein M; McPherson PS; Nagy A; Wang YT; Roder JC; Raymond LA; Hayden MR
EMBO J; 2003 Jul; 22(13):3254-66. PubMed ID: 12839988
[TBL] [Abstract][Full Text] [Related]
33. Epidermal growth factor receptor as a therapeutic target in veterinary oncology.
Bergkvist GT; Yool DA
Vet Comp Oncol; 2011 Jun; 9(2):81-94. PubMed ID: 21569194
[TBL] [Abstract][Full Text] [Related]
34. HIP1 and HIP12 display differential binding to F-actin, AP2, and clathrin. Identification of a novel interaction with clathrin light chain.
Legendre-Guillemin V; Metzler M; Charbonneau M; Gan L; Chopra V; Philie J; Hayden MR; McPherson PS
J Biol Chem; 2002 May; 277(22):19897-904. PubMed ID: 11889126
[TBL] [Abstract][Full Text] [Related]
35. Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases.
Ames HM; Wang AA; Coughran A; Evaul K; Huang S; Graves CW; Soyombo AA; Ross TS
Mol Cell Biol; 2013 Sep; 33(18):3580-93. PubMed ID: 23836884
[TBL] [Abstract][Full Text] [Related]
36. Elevated serum epidermal growth factor receptor level in stage IV thymoma.
Sasaki H; Yukiue H; Sekimura A; Mizuno K; Konishi A; Yano M; Fukai I; Fujii Y
Surg Today; 2004; 34(5):477-9. PubMed ID: 15108095
[TBL] [Abstract][Full Text] [Related]
37. The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-binding protein involved in receptor-mediated endocytosis.
Waelter S; Scherzinger E; Hasenbank R; Nordhoff E; Lurz R; Goehler H; Gauss C; Sathasivam K; Bates GP; Lehrach H; Wanker EE
Hum Mol Genet; 2001 Aug; 10(17):1807-17. PubMed ID: 11532990
[TBL] [Abstract][Full Text] [Related]
38. Knockdown of HIP1 expression promotes ligand‑induced endocytosis of EGFR in HeLa cells.
Li D; Chen F; Ding J; Lin N; Li Z; Wang X
Oncol Rep; 2017 Dec; 38(6):3387-3391. PubMed ID: 29039605
[TBL] [Abstract][Full Text] [Related]
39. Actin binding by Hip1 (huntingtin-interacting protein 1) and Hip1R (Hip1-related protein) is regulated by clathrin light chain.
Wilbur JD; Chen CY; Manalo V; Hwang PK; Fletterick RJ; Brodsky FM
J Biol Chem; 2008 Nov; 283(47):32870-9. PubMed ID: 18790740
[TBL] [Abstract][Full Text] [Related]
40. Huntingtin-interacting protein 1 (Hip1) and Hip1-related protein (Hip1R) bind the conserved sequence of clathrin light chains and thereby influence clathrin assembly in vitro and actin distribution in vivo.
Chen CY; Brodsky FM
J Biol Chem; 2005 Feb; 280(7):6109-17. PubMed ID: 15533940
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
